CCNG1 and osteosarcoma: Human cyclin G1 (CCNG1), in particular, garnered interest following the work of Frederick L. Hall et al. in 1994 who first characterized the human CCNG1 gene via molecular cloning and demonstrated overexpression of the cyclin G1 oncogene that was independent of the p53 tumor suppressor in osteosarcoma cell lines [16].